Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 418 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(2S)-2-([N-[(benzyloxy)carbonyl]-L-leucyl]amino)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonic acid - Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(2Z)-3-[4-oxo-2-(pyridin-3-yl)-1,4-dihydroquinolin-6-yl]prop-2-enoic acid 70% effect at 0.1 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(3S)-[N3-(acetyl-L-leucyl-L-alanyl)-N1-[3'-(N,N-dimethylamino)-3'-oxopropyl]-N1-(methylsulfonyl)]-1,3-diaminobutan-2-one weak competitive Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(3S)-[N3-(acetyl-L-leucyl-L-alanyl)-N1-[3'-(N,N-dimethylamino)-3'-oxopropyl]-N1-(p-methylphenylsulfonyl)]-1,3-diaminobutan-2-one weak competitive Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(3S)-[N3-(benzyloxycarbonyl)-N1-[3'-(N,N-dimethylamino)-3'-oxoprolyl]-N1-(methylsulfonyl)]-1,3-diaminobutan-2-one weak competitive Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(3S)-[N3-(benzyloxycarbonyl)-N1-[3'-(N,N-dimethylamino)-3'-oxopropyl]-N1-(p-methylphenylsulfonyl)]-1,3-diaminobutan-2-one weak competitive, IC50: 0.075 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(4R,5R)-N-(1,3-benzothiazol-2-yl)-2,2-dimethyl-5-[(4-phenylpiperazin-1-yl)carbonyl]-1,3-dioxolane-4-carboxamide 82.47% inhibition at 0.1 mM; complete inhibition at 0.1 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(4R,5R)-N-(1,3-benzothiazol-2-yl)-2,2-dimethyl-5-[[4-(3-methylbenzyl)piperazin-1-yl]carbonyl]-1,3-dioxolane-4-carboxamide 78.74% inhibition at 0.1 mM; 84.20% inhibition at 0.1 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(4R,5R)-N-(1,3-benzothiazol-2-yl)-2,2-dimethyl-5-[[4-(pyridin-2-yl)piperazin-1-yl]carbonyl]-1,3-dioxolane-4-carboxamide 85.35% inhibition at 0.1 mM; 97.80% inhibition at 0.1 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.28(4R,5R)-N-(1,3-benzothiazol-2-yl)-5-[(4-benzylpiperazin-1-yl)carbonyl]-2,2-dimethyl-1,3-dioxolane-4-carboxamide 67.80% inhibition at 0.1 mM; 85.51% inhibition at 0.1 mM, molecular docking study using the HRV 3C protease structure, PDB ID 1CQQ Go to the Ligand Summary Page
Results 1 - 10 of 418 > >>
download as CSV
download all results as CSV